Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model.

Perinatal hypoxic ischemic encephalopathy (HIE) remains a major contributor of infant death and long-term disability worldwide. The role played by the complement system in this ischemia-reperfusion injury remains poorly understood. In order to better understand the role of complement activation and...

Full description

Bibliographic Details
Main Authors: Parvathi Kumar, Pamela Hair, Kenji Cunnion, Neel Krishna, Thomas Bass
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0257960
_version_ 1818990347193155584
author Parvathi Kumar
Pamela Hair
Kenji Cunnion
Neel Krishna
Thomas Bass
author_facet Parvathi Kumar
Pamela Hair
Kenji Cunnion
Neel Krishna
Thomas Bass
author_sort Parvathi Kumar
collection DOAJ
description Perinatal hypoxic ischemic encephalopathy (HIE) remains a major contributor of infant death and long-term disability worldwide. The role played by the complement system in this ischemia-reperfusion injury remains poorly understood. In order to better understand the role of complement activation and other modifiable mechanisms of injury in HIE, we tested the dual-targeting anti-inflammatory peptide, RLS-0071 in an animal model of HIE. Using the well-established HIE rat pup model we measured the effects of RLS-0071 during the acute stages of the brain injury and on long-term neurocognitive outcomes. Rat pups subject to hypoxia-ischemia insult received one of 4 interventions including normothermia, hypothermia and RLS-0071 with and without hypothermia. We measured histopathological effects, brain C1q levels and neuroimaging at day 1 and 21 after the injury. A subset of animals was followed into adolescence and evaluated for neurocognitive function. On histological evaluation, RLS-0071 showed neuronal protection in combination with hypothermia (P = 0.048) in addition to reducing C1q levels in the brain at 1hr (P = 0.01) and at 8 hr in combination with hypothermia (P = 0.005). MRI neuroimaging demonstrated that RLS-0071 in combination with hypothermia reduced lesion volume at 24 hours (P<0.05) as well as decreased T2 signal at day 21 in combination with hypothermia (P<0.01). RLS-0071 alone or in combination with hypothermia improved both short-term and long-term memory. These findings suggest that modulation by RLS-0071 can potentially decrease brain damage resulting from HIE.
first_indexed 2024-12-20T19:52:55Z
format Article
id doaj.art-632e0da05f98427c83b68800875cdff9
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T19:52:55Z
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-632e0da05f98427c83b68800875cdff92022-12-21T19:28:15ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01169e025796010.1371/journal.pone.0257960Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model.Parvathi KumarPamela HairKenji CunnionNeel KrishnaThomas BassPerinatal hypoxic ischemic encephalopathy (HIE) remains a major contributor of infant death and long-term disability worldwide. The role played by the complement system in this ischemia-reperfusion injury remains poorly understood. In order to better understand the role of complement activation and other modifiable mechanisms of injury in HIE, we tested the dual-targeting anti-inflammatory peptide, RLS-0071 in an animal model of HIE. Using the well-established HIE rat pup model we measured the effects of RLS-0071 during the acute stages of the brain injury and on long-term neurocognitive outcomes. Rat pups subject to hypoxia-ischemia insult received one of 4 interventions including normothermia, hypothermia and RLS-0071 with and without hypothermia. We measured histopathological effects, brain C1q levels and neuroimaging at day 1 and 21 after the injury. A subset of animals was followed into adolescence and evaluated for neurocognitive function. On histological evaluation, RLS-0071 showed neuronal protection in combination with hypothermia (P = 0.048) in addition to reducing C1q levels in the brain at 1hr (P = 0.01) and at 8 hr in combination with hypothermia (P = 0.005). MRI neuroimaging demonstrated that RLS-0071 in combination with hypothermia reduced lesion volume at 24 hours (P<0.05) as well as decreased T2 signal at day 21 in combination with hypothermia (P<0.01). RLS-0071 alone or in combination with hypothermia improved both short-term and long-term memory. These findings suggest that modulation by RLS-0071 can potentially decrease brain damage resulting from HIE.https://doi.org/10.1371/journal.pone.0257960
spellingShingle Parvathi Kumar
Pamela Hair
Kenji Cunnion
Neel Krishna
Thomas Bass
Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model.
PLoS ONE
title Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model.
title_full Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model.
title_fullStr Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model.
title_full_unstemmed Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model.
title_short Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model.
title_sort classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model
url https://doi.org/10.1371/journal.pone.0257960
work_keys_str_mv AT parvathikumar classicalcomplementpathwayinhibitionreducesbraindamageinahypoxicischemicencephalopathyanimalmodel
AT pamelahair classicalcomplementpathwayinhibitionreducesbraindamageinahypoxicischemicencephalopathyanimalmodel
AT kenjicunnion classicalcomplementpathwayinhibitionreducesbraindamageinahypoxicischemicencephalopathyanimalmodel
AT neelkrishna classicalcomplementpathwayinhibitionreducesbraindamageinahypoxicischemicencephalopathyanimalmodel
AT thomasbass classicalcomplementpathwayinhibitionreducesbraindamageinahypoxicischemicencephalopathyanimalmodel